2025 annual financial data
MIRA Pharmaceuticals 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -10,493,112 USD and net income was -10,442,485 USD.
Operating cash flow was -4,661,669 USD.
Get free MIRA Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -10,493,112 USD
- Net income
- -10,442,485 USD
- Operating cash flow
- -4,661,669 USD